{"id":"https://openalex.org/W2001126308","doi":"https://doi.org/10.3892/ijo.23.1.151","title":"Synergistic growth inhibitory effects of interferon-\u03b1 and lovastatin on bcr-abl positive leukemic cells","display_name":"Synergistic growth inhibitory effects of interferon-\u03b1 and lovastatin on bcr-abl positive leukemic cells","publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W2001126308","doi":"https://doi.org/10.3892/ijo.23.1.151","mag":"2001126308","pmid":"https://pubmed.ncbi.nlm.nih.gov/12792788"},"language":"en","primary_location":{"id":"doi:10.3892/ijo.23.1.151","doi":"https://doi.org/10.3892/ijo.23.1.151","is_oa":false,"landing_page_url":"https://doi.org/10.3892/ijo.23.1.151","pdf_url":null,"source":{"id":"https://openalex.org/S4210208883","display_name":"International Journal of Oncology","issn_l":"1019-6439","issn":["1019-6439","1791-2423"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-d","jufo-1","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028388949","display_name":"Carsten M\u00fcller\u2010Tidow","orcid":"https://orcid.org/0000-0002-7166-5232","observed_orcids":["https://orcid.org/0000-0002-7166-5232"]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carsten M\u00fcller-Tidow","raw_affiliation_strings":["Department of Medicine, Hematology/Oncology, University of M\u00fcnster, D-48129 M\u00fcnster, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Hematology/Oncology, University of M\u00fcnster, D-48129 M\u00fcnster, Germany","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048939350","display_name":"Michael G Kiehl","orcid":"https://orcid.org/0000-0002-0216-3861","observed_orcids":["https://orcid.org/0000-0002-0216-3861"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Kiehl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109975555","display_name":"J\u00fcrgen Reinhard Sindermann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J\u00fcrgen Sindermann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109851806","display_name":"Michael Probst","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Probst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031132241","display_name":"Nicola Banger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicola Banger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113846222","display_name":"Michael Zu\u0308hlsdorf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Z\u00fchlsdorf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026225196","display_name":"Ting\u2010Chao Chou","orcid":"https://orcid.org/0000-0002-3340-1594","observed_orcids":["https://orcid.org/0000-0002-3340-1594"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ting-Chao Chou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025105470","display_name":"Wolfgang E. Berdel","orcid":"https://orcid.org/0000-0002-3030-6567","observed_orcids":["https://orcid.org/0000-0002-3030-6567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Berdel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086016311","display_name":"Hubert L. Serve","orcid":"https://orcid.org/0000-0001-8472-5516","observed_orcids":["https://orcid.org/0000-0001-8472-5516"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hubert Serve","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088803850","display_name":"Olaf Koch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olaf Koch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6824,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.69102862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"23","issue":"1","first_page":"151","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.9369999766349792},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9139999747276306},{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":1.0},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9309999942779541},{"id":"https://openalex.org/keywords/ras-p21","display_name":"p21ras","score":0.6660000085830688},{"id":"https://openalex.org/keywords/protein-farnesylation","display_name":"farnesylation","score":0.828000009059906},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.5690000057220459},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6110000014305115},{"id":"https://openalex.org/keywords/protein-phosphorylation","display_name":"protein phosphorylation","score":0.875},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9129999876022339},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.9610000252723694},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6916382908821106},{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.6296560764312744},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.6253596544265747},{"id":"https://openalex.org/C171122931","wikidata":"https://www.wikidata.org/wiki/Q6324626","display_name":"K562 cells","level":3,"score":0.6050536036491394},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5930443406105042},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.49679258465766907},{"id":"https://openalex.org/C2777553839","wikidata":"https://www.wikidata.org/wiki/Q14330986","display_name":"Tyrosine phosphorylation","level":3,"score":0.4848233759403229},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.47102174162864685},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.46655458211898804},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.42969250679016113},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3181838393211365},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2930983304977417},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.24087312817573547},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21457794308662415},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008798","descriptor_name":"Mevalonic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011499","descriptor_name":"Protein Processing, Post-Translational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012694","descriptor_name":"Serine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013912","descriptor_name":"Threonine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014443","descriptor_name":"Tyrosine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017368","descriptor_name":"Protein Prenylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020014","descriptor_name":"K562 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053938","descriptor_name":"DNA Fragmentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3892/ijo.23.1.151","doi":"https://doi.org/10.3892/ijo.23.1.151","is_oa":false,"landing_page_url":"https://doi.org/10.3892/ijo.23.1.151","pdf_url":null,"source":{"id":"https://openalex.org/S4210208883","display_name":"International Journal of Oncology","issn_l":"1019-6439","issn":["1019-6439","1791-2423"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-d","jufo-1","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Oncology","raw_type":"journal-article"},{"id":"pmid:12792788","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12792788","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2045423970","https://openalex.org/W2019665042","https://openalex.org/W2079053651","https://openalex.org/W2413024737","https://openalex.org/W2040113930","https://openalex.org/W2470659933","https://openalex.org/W1572714088","https://openalex.org/W1841618081","https://openalex.org/W2427716441","https://openalex.org/W2016086822"],"abstract_inverted_index":{"The":[0],"chimeric":[1],"bcr-abl":[2,17,82,182],"tyrosine":[3],"kinase":[4],"is":[5],"of":[6,24,34,46,59,69,95,109,136,160,168,181,189,207,211,219],"crucial":[7],"pathogenic":[8],"importance":[9],"in":[10,74,81,99,113,124,133,166,187,195,199],"chronic":[11],"myeloid":[12],"leukemia":[13],"(CML).":[14],"As":[15],"shown,":[16],"activates":[18],"the":[19,39,66,208],"ras":[20],"pathway":[21],"by":[22,42,72],"phosphorylation":[23,137,153,191],"adapter":[25],"proteins":[26,51],"such":[27],"as":[28,56,104,106,215],"Grb-2":[29],"and":[30,121,131,141,176,185,192],"Crkl.":[31],"Functional":[32],"inhibition":[33],"p21ras":[35,50],"might":[36],"partially":[37],"inhibit":[38],"mitogenic":[40],"signaling":[41],"bcr-abl.":[43],"By":[44],"depletion":[45,71],"cellular":[47],"mevalonate":[48,70],"pools,":[49],"can":[52],"be":[53],"rendered":[54],"non-functional":[55],"a":[57,100,114],"result":[58],"deficient":[60],"post-translational":[61],"protein":[62,143,152,190],"farnesylation.":[63],"We":[64],"investigated":[65],"pharmacologic":[67],"effect":[68,150],"lovastatin":[73,157,177],"conjunction":[75],"with":[76,116,221],"interferon-alpha":[77],"2b":[78,123,146,175],"(INF-alpha":[79],"2b)":[80],"positive":[83,183],"K562":[84,98,196],"cells.":[85,169,197],"At":[86],"various":[87],"concentrations,":[88],"both":[89],"drugs":[90],"synergistically":[91,178],"reduced":[92],"cell":[93,128],"proliferation":[94,180],"CML":[96,220],"line":[97],"liquid":[101],"culture":[102],"system":[103],"well":[105],"clonal":[107],"growth":[108],"colony":[110],"forming":[111],"units":[112],"patient":[115],"newly":[117],"diagnosed":[118],"CML.":[119],"Lovastatin":[120],"IFN-alpha":[122,145,174],"combination":[125],"led":[126],"to":[127,173,217],"cycle":[129],"arrest":[130],"resulted":[132,186],"significant":[134],"reduction":[135],"on":[138,151],"tyrosine,":[139],"serine,":[140],"threonine":[142],"residues.":[144],"alone":[147],"showed":[148],"little":[149],"but":[154],"strongly":[155],"enhanced":[156],"driven":[158],"loss":[159,188],"phosphorylation.":[161],"Subsequently,":[162],"DNA":[163],"fragmentation":[164],"occurred":[165],"50%":[167],"In":[170],"conclusion,":[171],"exposure":[172],"inhibited":[179],"cells":[184],"subsequent":[193],"apoptosis":[194],"Our":[198],"vitro":[200],"model":[201],"suggests":[202],"further":[203],"investigations":[204],"are":[205],"required":[206],"potential":[209],"value":[210],"HMG-CoA":[212],"reductase":[213],"inhibitors":[214],"adjunct":[216],"therapy":[218],"interferon.":[222]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}